发布求助
文献互助 智能选刊 最新文献

E-Posters (Trials In Progress)最新文献

筛选
英文 中文
TP030/#1426 EPIK-O/ENGOT-OV61: a phase 3, randomized study of alpelisib + olaparib in patients with no germline BRCA mutation detected, platinum-resistant or -refractory, high-grade serous ovarian cancer EPIK-O/ENGOT-OV61:一项3期随机研究，alpelisib + olaparib治疗未检测到种系BRCA突变、铂耐药或难治的高级别浆液性卵巢癌患者
E-Posters (Trials In Progress) Pub Date : 2022-12-01 DOI: 10.1136/ijgc-2022-igcs.539
P. Konstantinopoulos, A. González-Martín, F. Cruz, M. Friedlander, R. Glasspool, D. Lorusso, C. Marth, B. Monk, Jae-Weon Kim, Olga Ajipa, F. Su, Yu Han, U. Matulonis
{"title":"TP030/#1426 EPIK-O/ENGOT-OV61: a phase 3, randomized study of alpelisib + olaparib in patients with no germline BRCA mutation detected, platinum-resistant or -refractory, high-grade serous ovarian cancer","authors":"P. Konstantinopoulos, A. González-Martín, F. Cruz, M. Friedlander, R. Glasspool, D. Lorusso, C. Marth, B. Monk, Jae-Weon Kim, Olga Ajipa, F. Su, Yu Han, U. Matulonis","doi":"10.1136/ijgc-2022-igcs.539","DOIUrl":"https://doi.org/10.1136/ijgc-2022-igcs.539","url":null,"abstract":"","PeriodicalId":105919,"journal":{"name":"E-Posters (Trials In Progress)","volume":"4 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122166667","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TP016/#1442 Keynote-C93/GOG-3064/ENGOT-EN15: phase 3, randomized, open-label study of first-line pembrolizumab versus platinum-doublet chemotherapy in mismatch repair deficient advanced or recurrent endometrial carcinoma Keynote-C93/GOG-3064/ENGOT-EN15:一线派姆单抗与铂双药化疗治疗错配修复缺陷晚期或复发子宫内膜癌的3期随机开放标签研究
E-Posters (Trials In Progress) Pub Date : 2022-12-01 DOI: 10.1136/ijgc-2022-igcs.525
B. Slomovitz, D. Cibula, M. Gultekin, M. Mirza, B. Maćkowiak-Matejczyk, A. Taylor, I. Romero, N. Colombo, J. Korach, Jianqing Zhu, L. Gilbert, K. Hasegawa, Jae-Weon Kim, S. Baron-Hay, V. Makker, R. Coleman, R. Orlowski, Xuan Zhou, V. Khemka, S. Pignata
{"title":"TP016/#1442 Keynote-C93/GOG-3064/ENGOT-EN15: phase 3, randomized, open-label study of first-line pembrolizumab versus platinum-doublet chemotherapy in mismatch repair deficient advanced or recurrent endometrial carcinoma","authors":"B. Slomovitz, D. Cibula, M. Gultekin, M. Mirza, B. Maćkowiak-Matejczyk, A. Taylor, I. Romero, N. Colombo, J. Korach, Jianqing Zhu, L. Gilbert, K. Hasegawa, Jae-Weon Kim, S. Baron-Hay, V. Makker, R. Coleman, R. Orlowski, Xuan Zhou, V. Khemka, S. Pignata","doi":"10.1136/ijgc-2022-igcs.525","DOIUrl":"https://doi.org/10.1136/ijgc-2022-igcs.525","url":null,"abstract":"","PeriodicalId":105919,"journal":{"name":"E-Posters (Trials In Progress)","volume":"15 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116753339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
TP040/#1418 Palbociclib plus letrozole combination after progression on second-line chemotherapy for women with ER/PR-positive high-grade serous or endometrioid ovarian, fallopian tube or peritoneal cancer (LACOG 1018) Palbociclib +来曲唑联合治疗ER/ pr阳性的高级别浆液性或子宫内膜样卵巢癌、输卵管癌或腹膜癌患者的二线化疗进展(LACOG 1018)
E-Posters (Trials In Progress) Pub Date : 2022-12-01 DOI: 10.1136/ijgc-2022-igcs.549
F. Damian, G. D. Molin, A. Rodrigues, A. Calabrich, G. Werutsky, E. A. Filho, M. F. Jiménez, T. Rebelatto, R. D. Jesus, A. Melo
{"title":"TP040/#1418 Palbociclib plus letrozole combination after progression on second-line chemotherapy for women with ER/PR-positive high-grade serous or endometrioid ovarian, fallopian tube or peritoneal cancer (LACOG 1018)","authors":"F. Damian, G. D. Molin, A. Rodrigues, A. Calabrich, G. Werutsky, E. A. Filho, M. F. Jiménez, T. Rebelatto, R. D. Jesus, A. Melo","doi":"10.1136/ijgc-2022-igcs.549","DOIUrl":"https://doi.org/10.1136/ijgc-2022-igcs.549","url":null,"abstract":"","PeriodicalId":105919,"journal":{"name":"E-Posters (Trials In Progress)","volume":"33 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125695752","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TP001/#1553 GOG-3043 (NCT04831580): a randomized non-inferiority trial of robotic versus open radical hysterectomy for early stage cervical cancer (ROCC) GOG-3043 (NCT04831580):机器人与开放式根治性子宫切除术治疗早期宫颈癌(ROCC)的随机非效性试验
E-Posters (Trials In Progress) Pub Date : 2022-12-01 DOI: 10.1136/ijgc-2022-igcs.510
K. Bixel, Mario Leitao, D. Chase, Allison Quick, Peter Lim, R. Eskander, W. Gotlieb, S. Lococo, Martin Martino, C. Mccormick, T. Myers, K. Tewari, B. Slomovitz, Joan Walker, Larry Copeland, B. Monk, L. Randall
{"title":"TP001/#1553 GOG-3043 (NCT04831580): a randomized non-inferiority trial of robotic versus open radical hysterectomy for early stage cervical cancer (ROCC)","authors":"K. Bixel, Mario Leitao, D. Chase, Allison Quick, Peter Lim, R. Eskander, W. Gotlieb, S. Lococo, Martin Martino, C. Mccormick, T. Myers, K. Tewari, B. Slomovitz, Joan Walker, Larry Copeland, B. Monk, L. Randall","doi":"10.1136/ijgc-2022-igcs.510","DOIUrl":"https://doi.org/10.1136/ijgc-2022-igcs.510","url":null,"abstract":"","PeriodicalId":105919,"journal":{"name":"E-Posters (Trials In Progress)","volume":"43 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123400298","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TP014/#1529 Randomized comparison between sentinel lymph node mapping using indocyanine green plus a fluorescent camera versus lymph node dissection in clinical stage I-II endometrial cancer (KGOG2029/SELYE) 临床I-II期子宫内膜癌前哨淋巴结定位使用吲哚菁绿加荧光相机与淋巴结清扫的随机比较
E-Posters (Trials In Progress) Pub Date : 2022-12-01 DOI: 10.1136/ijgc-2022-igcs.523
J. Park, E. Park, Sang Wun Kim
{"title":"TP014/#1529 Randomized comparison between sentinel lymph node mapping using indocyanine green plus a fluorescent camera versus lymph node dissection in clinical stage I-II endometrial cancer (KGOG2029/SELYE)","authors":"J. Park, E. Park, Sang Wun Kim","doi":"10.1136/ijgc-2022-igcs.523","DOIUrl":"https://doi.org/10.1136/ijgc-2022-igcs.523","url":null,"abstract":"","PeriodicalId":105919,"journal":{"name":"E-Posters (Trials In Progress)","volume":"90 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121497690","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TP008/#1422 Epidemiological landscape of cervical cancer in Latin America (EVITA LATAM) – LACOG 0820 拉丁美洲宫颈癌流行病学概况(EVITA LATAM) - LACOG 0820
E-Posters (Trials In Progress) Pub Date : 2022-12-01 DOI: 10.1136/ijgc-2022-igcs.517
{"title":"TP008/#1422 Epidemiological landscape of cervical cancer in Latin America (EVITA LATAM) – LACOG 0820","authors":"","doi":"10.1136/ijgc-2022-igcs.517","DOIUrl":"https://doi.org/10.1136/ijgc-2022-igcs.517","url":null,"abstract":"Graziela Zibetti Dal Molin*, Mivael Olivera, Adrian Guerrero, Reitan Ribeiro, Juan Zarba, Andreia Cristina De Melo, Gustavo Werutsky, Heloisa De Andrade Carvalho, Juan Velasquez, Alexssandra Siqueira Dos Santos, Fernanda Damian, Eduardo Cronemberg, André Mattar, Lucely Cetina-Perez, Miriam Raimondo, Natalia Baltz Hehn, Ronaldo Schmidt, Vanessa Bezerra, Rafaela De Jesus, Taiane Rebelatto, Renata Colombo Bonadio. Hospital Beneficência Portuguesa de São Paulo, Medical Oncology, São Paulo, Brazil; Latin American Cooperative Oncology Group (LACOG), Oncology, Porto Alegre, Brazil; Instituto Nacional de Enfermedades Neoplásicas, Gecoperu, Lima, Peru; Universidad Autónoma de Santo Domingo (UASD), Instituto Nacional del Cáncer Rosa E. Sánchez (INCART), Oncology, Santo Domingo, Dominican Republic; Erasto Gaertner Hospital, Oncology, Curitiba, Brazil; Centro Medico San Roque Exelsus, Oncología Clínica, San Miguel de Tucumán, Argentina; Instituto Nacional de Câncer, Oncologia Clínica, Rio de Janeiro, Brazil; Latin America Cooperative Oncology Group, Chair, Porto Alegre, Brazil; Hospital das Clínicas da Universidade de São Paulo, Oncology, São Paulo, Brazil; Instituto Nacional Cancerologia, Oncology, Bogotá, Colombia; Hospital São Lucas da PUCRS, Oncology, Porto Alegre, Brazil; Centro Regional Integrado de Oncologia (CRIO), Oncology, Fortaleza, Brazil; Hospital Pérola Byington, Oncology, São Paulo, Brazil; Instituto Nacional Cancerologia (INCAN), Gynecology Oncology, Ciudad de México, Mexico; Sanatorio de La Mujer, Oncology, Rosario, Argentina; Fundación CENIT, Oncology, Buenos Aires, Argentina; Barretos Cancer Hospital, Oncology, Barretos, Brazil; Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein, Ginecologia Oncológica, São Paulo, Brazil; Latin America Cooperative Oncology Group, Statistics, Porto Alegre, Brazil; Instituto do Cancer do Estado de Sao Paulo, Medical Oncologist, São Paulo, Brazil; Faculdade de Medicina da Universidade de São Paulo, Oncology, São Paulo, Brazil","PeriodicalId":105919,"journal":{"name":"E-Posters (Trials In Progress)","volume":"15 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132772240","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TP027/#586 A multicenter study of niraparib maintenance therapy in BRCA wild-type, newly diagnosed advanced ovarian cancer: polo trial 尼拉帕尼维持治疗BRCA野生型新诊断晚期卵巢癌的多中心研究:polo试验
E-Posters (Trials In Progress) Pub Date : 2022-12-01 DOI: 10.1136/ijgc-2022-igcs.536
S. I. Kim, Jung-Yun Lee, Byoung-Gie Kim, C. Choi, J. Park, M. Lim, Jae-Weon Kim
{"title":"TP027/#586 A multicenter study of niraparib maintenance therapy in BRCA wild-type, newly diagnosed advanced ovarian cancer: polo trial","authors":"S. I. Kim, Jung-Yun Lee, Byoung-Gie Kim, C. Choi, J. Park, M. Lim, Jae-Weon Kim","doi":"10.1136/ijgc-2022-igcs.536","DOIUrl":"https://doi.org/10.1136/ijgc-2022-igcs.536","url":null,"abstract":"","PeriodicalId":105919,"journal":{"name":"E-Posters (Trials In Progress)","volume":"9 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124303926","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TP032/#1532 Oregovomab and non-platinum single agent chemotherapy in parp inhibitor-resistant ovarian cancer patients not candidate for platinum retreatment: a multi-cohort phase II study (KGOG 3065/APGOT-OV6) Oregovomab和非铂单药化疗治疗parp抑制剂耐药卵巢癌患者不适合铂再治疗:多队列II期研究(KGOG 3065/APGOT-OV6)
E-Posters (Trials In Progress) Pub Date : 2022-12-01 DOI: 10.1136/ijgc-2022-igcs.541
Young Joo Lee, Jung-Yun Lee, Junsik Park, Y. Lee, Sunghoon Kim, Y. Lee, C. Choi, Byoung-Gie Kim, H. Kim, Jae-Weon Kim, S. Jada
{"title":"TP032/#1532 Oregovomab and non-platinum single agent chemotherapy in parp inhibitor-resistant ovarian cancer patients not candidate for platinum retreatment: a multi-cohort phase II study (KGOG 3065/APGOT-OV6)","authors":"Young Joo Lee, Jung-Yun Lee, Junsik Park, Y. Lee, Sunghoon Kim, Y. Lee, C. Choi, Byoung-Gie Kim, H. Kim, Jae-Weon Kim, S. Jada","doi":"10.1136/ijgc-2022-igcs.541","DOIUrl":"https://doi.org/10.1136/ijgc-2022-igcs.541","url":null,"abstract":"","PeriodicalId":105919,"journal":{"name":"E-Posters (Trials In Progress)","volume":"23 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121763900","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TP041/#1460 The culture of advanced or recurrent ovarian cancer organoids and drug screening 晚期或复发性卵巢癌类器官的培养和药物筛选
E-Posters (Trials In Progress) Pub Date : 2022-12-01 DOI: 10.1136/ijgc-2022-igcs.550
Haixia Wang, Misi He, Ling Wang, Xueping Zhu, D. Zou
{"title":"TP041/#1460 The culture of advanced or recurrent ovarian cancer organoids and drug screening","authors":"Haixia Wang, Misi He, Ling Wang, Xueping Zhu, D. Zou","doi":"10.1136/ijgc-2022-igcs.550","DOIUrl":"https://doi.org/10.1136/ijgc-2022-igcs.550","url":null,"abstract":"","PeriodicalId":105919,"journal":{"name":"E-Posters (Trials In Progress)","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129788586","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TP026/#1435 Phase 3 study of efficacy & safety of Olvi-Vec and platinum-doublet + bevacizumab compared to platinum-doublet + bevacizumab in platinum-resistant/refractory ovarian cancer (ONPRIME; GOG-3076) [NCT05281471] t026 /#1435:与双铂+贝伐单抗相比，Olvi-Vec和双铂+贝伐单抗治疗铂耐药/难治性卵巢癌的疗效和安全性的3期研究(ONPRIME;高格- 3076)[NCT05281471]
E-Posters (Trials In Progress) Pub Date : 2022-12-01 DOI: 10.1136/ijgc-2022-igcs.535
Robert W Holloway, P. Thaker, A. Mendivil, Sarfraz Ahmad, M. Bell, S. Chambers, John K. Chan, R. Coleman, Sarah Crafton, Erin P. Crane, R. Eskander, Karen Finkelstein, W. Graybill, T. Herzog, V. John, L. Landrum, A. Leiser, Michael Mchale, Rachel Miller, B. Monk, K. Moore, D. O’Malley, T. Reid, D. Richardson, D. Silasi, J. Sunde, K. Tewari
{"title":"TP026/#1435 Phase 3 study of efficacy & safety of Olvi-Vec and platinum-doublet + bevacizumab compared to platinum-doublet + bevacizumab in platinum-resistant/refractory ovarian cancer (ONPRIME; GOG-3076) [NCT05281471]","authors":"Robert W Holloway, P. Thaker, A. Mendivil, Sarfraz Ahmad, M. Bell, S. Chambers, John K. Chan, R. Coleman, Sarah Crafton, Erin P. Crane, R. Eskander, Karen Finkelstein, W. Graybill, T. Herzog, V. John, L. Landrum, A. Leiser, Michael Mchale, Rachel Miller, B. Monk, K. Moore, D. O’Malley, T. Reid, D. Richardson, D. Silasi, J. Sunde, K. Tewari","doi":"10.1136/ijgc-2022-igcs.535","DOIUrl":"https://doi.org/10.1136/ijgc-2022-igcs.535","url":null,"abstract":"","PeriodicalId":105919,"journal":{"name":"E-Posters (Trials In Progress)","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128707359","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信
小红书